BioMendics advances its TAMES-02 trial of TolaSure™, a potential disease-modifying topical therapy for Epidermolysis Bullosa ...

Gilead Sciences GILD recently announced that it has exercised its combined option to exclusively license Assembly Biosciences’ ASMB herpes simplex virus (HSV) helicase-primase inhibitor programs. The ...

Gilead licensed Assembly Bio's long-acting HSV drugs after Phase 1b data showed antiviral activity and weekly oral dosing potential.

The biggest stories of the day delivered to your inbox.

As power density soars, air and single-phase loops hit their limits. A new webinar from Advanced Cooling technologies (ACT) shows how loop thermosyphons and pumped two-phase cooling unlock higher ...

Pritelivir demonstrated clinically meaningful and highly statistically significant superiority (p=0.0047) in lesion healing up to 28 days of treatment, compared with standard-of-care (SoC) treatments ...

Ashes of Creation is back for testing. Those who have access to the alpha keys can jump into the game and test out plenty of new and updated features. Phase 3 of the Alpha 2 testing window has got a ...

LNG Canada awarded Flour Corp.’s joint venture with JGC Corp. the contract to update the front-end engineering and design (FEED) for a proposed Phase 2 expansion of the 14-million tonne/year LNG ...

A hope for reducing treatment burden for wet age-related macular degeneration with a sustained-release vorolanib intravitreal insert Talcott’s presentation focused on phase 2 clinical trial results of ...